# Bioceptive, Inc.: Form D filings

Bioceptive, Inc., a biotechnology company in New Orleans, LA, filed 7 Form D notices with the SEC between 2011 and 2016. The latest, on January 29, 2016, reports $416,450 sold of a $650,000 offering to 16 investors.

Find out what Bioceptive, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Bioceptive%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Bioceptive%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fbioceptive-inc-1527900)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Bioceptive%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Bioceptive%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fbioceptive-inc-1527900)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Louisiana](https://specstream.ai/data/form-d/state/louisiana): 144 rows, by operating companies, filed since November 1, 2024, $7.20, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/louisiana
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: NEW ORLEANS BIOINNOVATION CENTER, 1441 CANAL STREET, SUITE 228, New Orleans, LA, 70112
- Phone: (504) 598-5233
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2011
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1527900

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 29, 2016 | New notice | $650,000 | $416,450 | $233,550 | 16 | Jan 18, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1527900/000152790016000001/0001527900-16-000001-index.htm) |
| Dec 30, 2013 | New notice | $1,500,000 | $1,250,000 | $250,000 | 12 | Dec 20, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1527900/000152790013000002/0001527900-13-000002-index.htm) |
| Mar 1, 2013 | Amendment | $1,100,000 | $1,063,610 | $36,390 | 0 | Oct 25, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1527900/000152790013000001/0001527900-13-000001-index.htm) |
| Oct 24, 2012 | New notice | $1,000,000 | $0 | $1,000,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1527900/000152790012000003/0001527900-12-000003-index.htm) |
| Mar 26, 2012 | Amendment | $250,000 | $40,000 | $210,000 | 2 | Mar 12, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1527900/000152790012000002/0001527900-12-000002-index.htm) |
| Mar 26, 2012 | New notice | $200,000 | $40,000 | $160,000 | 2 | Mar 12, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1527900/000152790012000001/0001527900-12-000001-index.htm) |
| Aug 15, 2011 | New notice | $135,000 | $135,000 | $0 | 3 | Aug 9, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1527900/000152790011000001/0001527900-11-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Joan Neuscheler | Director |  |
| Joseph Kumar Lovett | Director |  |
| Amit Kumar Rathi | Director |  |
| Orin Levy | Director |  |
| Shuchi Kumar Khurana | Executive Officer |  |
| Benjamin Cappiello | Executive Officer, Director |  |

## Other biotechnology companies in Louisiana that filed recently

- [28bio, Inc.](https://specstream.ai/data/form-d/company/28bio-inc-1769360) $8.5 million · Oct 29, 2026
- [Therapeutic Neuromodulation Systems LLC](https://specstream.ai/data/form-d/company/therapeutic-neuromodulation-systems-llc-2152054) $1.7 million · Sep 21, 2026

[Every Form D from the week of Jan 25, 2016](https://specstream.ai/data/form-d/week/2016-01-25) · [All recent filings in Louisiana](https://specstream.ai/data/form-d/state/louisiana) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Bioceptive, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).